Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC ABBV-744 | 2138861-99-9 | 100.0% | 491.55 | 100 MG
SDP

Catalog No. 5000437723
Encompass_Preferred

ABBV-744 is a first-in-class, orally active, and selective inhibitor of the BDII domain of BET family proteins. It has IC50 values ranging from 4 to 18 nM for BRD2, BRD3, BRD4, and BRDT. It is primarily metabolized by CYP3A4, and its agent-like properties enable the investigation of its antitumor efficacy and tolerability. It is for research use only.

  • First-in-class
  • Orally active
  • Selective inhibitor of the BDII domain of BET family proteins
  • Exhibits antitumor efficacy and tolerability

Catalog No. 50-004-37723 Supplier Medchemexpress LLC Supplier No. HY112090100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ABBV-744 is a first-in-class, orally active, and selective inhibitor of the BDII domain of BET family proteins. It has IC50 values ranging from 4 to 18 nM for BRD2, BRD3, BRD4, and BRDT. It is primarily metabolized by CYP3A4, and its agent-like properties enable the investigation of its antitumor efficacy and tolerability. It is for research use only.

  • First-in-class
  • Orally active
  • Selective inhibitor of the BDII domain of BET family proteins
  • Exhibits antitumor efficacy and tolerability

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.